Back to Hudson Bay Capital Management LP Hudson Bay Capital Management LP

IOVAIOVA

Showing 2 of 12 quarters

Position history for Hudson Bay Capital Management LPHudson Bay Capital Management LP's holdings in IOVANCE BIOTHERAPEUTICS INC

No. Hudson Bay Capital Management exited its IOVA (Iovance Biotherapeutics) position in Q4 2024. Its Q3 2024 13F listed 135,000 shares worth $1.3M. Hudson Bay Capital Management first reported IOVA in Q1 2022 and held it in 11 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$1.3M

Total Shares Change

-135,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$7.40
0
2024-Q3
Decreased
135,000
-46.0%
$1.3M0.0%$9.39
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used